About SH3 domain-binding protein 5
SH3 domain-binding protein 5 (SH3BP5) is a protein
from Homo sapiens identified by UniProt accession
O60239, 455 residues long.
MolForge cross-references it against 0 known binders and
133 disease associations.
Target properties
| Protein name | SH3 domain-binding protein 5 |
| UniProt accession | O60239 |
| Gene | SH3BP5 |
| Organism | Homo sapiens |
| Length | 455 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (133)
Diseases linked to this target (Open Targets).
- PHF-tau measurement · score 0.30
- diffuse plaque measurement · score 0.28
- neurodegenerative disease · score 0.24
- drug use measurement · score 0.13
- mean platelet volume · score 0.12
- apolipoprotein A 1 measurement · score 0.12
- Melnick-Needles syndrome · score 0.08
- pachyonychia congenita · score 0.08
- acute myeloid leukemia · score 0.08
- diffuse large B-cell lymphoma · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O60239-F1 | alphafold | PREDICTED | 70.63 | — |
Amino-acid sequence (455 residues)
MDAALKRSRS EEPAEILPPA RDEEEEEEEG MEQGLEEEEE VDPRIQGELE KLNQSTDDIN RRETELEDAR QKFRSVLVEA TVKLDELVKK IGKAVEDSKP YWEARRVARQ AQLEAQKATQ DFQRATEVLR AAKETISLAE QRLLEDDKRQ FDSAWQEMLN HATQRVMEAE QTKTRSELVH KETAARYNAA MGRMRQLEKK LKRAINKSKP YFELKAKYYV QLEQLKKTVD DLQAKLTLAK GEYKMALKNL EMISDEIHER RRSSAMGPRG CGVGAEGSST SVEDLPGSKP EPDAISVASE AFEDDSCSNF VSEDDSETQS VSSFSSGPTS PSEMPDQFPA VVRPGSLDLP SPVSLSEFGM MFPVLGPRSE CSGASSPECE VERGDRAEGA ENKTSDKANN NRGLSSSSGS GGSSKSQSST SPEGQALENR MKQLSLQCSK GRDGIIADIK MVQIG
Explore SH3 domain-binding protein 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets